CompletedNo phase
Validity, and Reliability of the Turkish Version of the Trapeziometacarpal Arthrosis Symptoms and Disability Questionnaire
Key facts
- Who runs it
- University of Gaziantep
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 41 people enrolled
- Started
- 1 Mar 2025
- Ended
- 16 May 2025
- Type of study
- Observational
- Treatments tested
- Validity and Reliability
- Record updated
- 29 May 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients aged 18 years or older,
- Diagnosis of Trapeziometacarpal arthrosis
Who cannot take part
- Surgery on the thumb and/or hand/wrist,
- Acute trauma to the thumb,
- Cognitive problems
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To our knowledge, a Turkish version of the TASD questionnaire, frequently used for assessing TMC arthrosis worldwide, does not currently exist. Therefore, proper translation and cross-cultural adaptation of the tool are necessary for non-English speaking patients. This study aimed to develop the Turkish version of the TASD questionnaire, and to demonstrate its reliability and validity for use in patients with TMC arthrosis.
The group in the trial
- Trapeziometacarpal arthrosis group
Patients aged 18 years or older, with a diagnosis of TMC arthrosis were included in the study.
Treatment: Validity and Reliability
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Cross-Cultural Adaptation, Validity, and Reliability of the Turkish Version of the Trapeziometacarpal Arthrosis Symptoms and Disability Questionnaire
- Record updated
- 29 May 2025